Literature DB >> 8626766

Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase.

M Arand1, H Wagner, F Oesch.   

Abstract

On the basis of the sequence similarity between mammalian epoxide hydrolases and bacterial haloalkane dehalogenase reported earlier (Arand, M., Grant, D. F., Beetham, J. K., Friedberg, T., Oesch, F., and Hammock, B. D. (1994) FEBS Lett. 338, 251-256; Beetham, J. K., Grant, D., Arand, M., Garbarino, J., Kiyosue, T., Pinot, F., Oesch, F., Belknap, W. R., Shinozaki, K., and hammock, B. D. (1995) DNA Cell. Biol. 14, 61-71) we selected candidate amino acid residues for the putative catalytic triad of the rat soluble epoxide hydrolase. The predicted amino acid residues were exchanged by site-directed mutagenesis of the epoxide hydrolase cDNA, followed by the expression of the respective mutant enzymes in Escherichia coli. A total of 25 different mutants were analyzed for their epoxide hydrolase activity toward the model substrate trans-stilbene oxide. In case of impaired catalytic activity of a given mutant, the structural integrity of the recombinant enzyme protein was assessed either by its ability to covalently bind the substrate trans-stilbene oxide or by affinity purification on benzyl thio-Sepharose, using the soluble epoxide hydrolase-specific competitive inhibitor 4-fluorochalcone oxide to release the bound enzyme from the affinity matrix. Of the mutants under investigation, only those with changes in the positions Asp333, Asp495, and His523 were completely inactive toward the model substrate trans-stilbene oxide while retaining the proper protein fold. These amino acids were exactly those previously predicted by sequence alignment. Exchange of the amino acid residues flanking the catalytic nucleophile Asp333 significantly changed the kinetic properties of the enzyme. Mutation of His332 to Gln had no apparent effect on the Km but led to a heavily reduced Vmax (5% that of the wild type) of the mutant enzyme, while the exchange of Trp334 against Phe strongly increased the Km (7-fold) and also moderately enhanced the Vmax (2-fold) of the corresponding mutant. Mutation of Trp540 apparently had a strong effect on the protein conformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626766     DOI: 10.1074/jbc.271.8.4223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.

Authors:  German A Gomez; Christophe Morisseau; Bruce D Hammock; David W Christianson
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

3.  Detoxication strategy of epoxide hydrolase-the basis for a novel threshold for definable genotoxic carcinogens.

Authors:  Franz Oesch; Jan Georg Hengstler; Michael Arand
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-01

4.  Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif.

Authors:  Christopher D Bahl; Kelli L Hvorecny; Christophe Morisseau; Scott A Gerber; Dean R Madden
Journal:  Biochemistry       Date:  2016-01-22       Impact factor: 3.162

5.  Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase.

Authors:  M Arand; H Hemmer; H Dürk; J Baratti; A Archelas; R Furstoss; F Oesch
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

6.  Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus.

Authors:  Jiawen Xu; Christophe Morisseau; Jun Yang; Dadala M Mamatha; Bruce D Hammock
Journal:  Insect Biochem Mol Biol       Date:  2015-02-14       Impact factor: 4.714

7.  Homology modeling of a novel epoxide hydrolase (EH) from Aspergillus niger SQ-6: structure-activity relationship in expoxides inhibiting EH activity.

Authors:  Quan Luo; Yuan Yao; Wei-Wei Han; Yi-Han Zhou; Ze-Sheng Li
Journal:  J Mol Model       Date:  2009-02-21       Impact factor: 1.810

8.  The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.

Authors:  Annette Cronin; Sherry Mowbray; Heike Dürk; Shirli Homburg; Ingrid Fleming; Beate Fisslthaler; Franz Oesch; Michael Arand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

9.  Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.

Authors:  Ding Ai; Yi Fu; Deliang Guo; Hiromasa Tanaka; Nanping Wang; Chaoshu Tang; Bruce D Hammock; John Y-J Shyy; Yi Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-10       Impact factor: 11.205

10.  Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.

Authors:  Seiya Kitamura; Kelli L Hvorecny; Jun Niu; Bruce D Hammock; Dean R Madden; Christophe Morisseau
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.